Latest Blogs

Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Subscribe to this column

Daniel F. Hayes, MD, FACP, FASCO

Daniel F. Hayes, MD, FACP, FASCO, is the 2016-2017 ASCO President. Dr. Hayes, a breast cancer specialist, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.

An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Mar 30, 2017
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Mar 07, 2017
I am pleased to share the news that ASCO volunteers, staff, and collaborators are already making progress on major expansions to ASCO's programs to address global oncology priorities.
Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
Nov 28, 2016
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  

Pages